Skip to search.
 BSE Down 0.37% NSE Down 0.29%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
12.03 28 Jul 1:30am
|Pre-Market : 12.22 Up 0.19 (1.58%) 6:47pm - Nasdaq Real Time Price
Add to Portfolio
Prev Close:12.03
Open:N/A
Bid:12.15 x 200
Ask:12.23 x 100
1y Target Est:13.25
Beta:0.19
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:N/A - N/A
52wk Range:2.31 - 14.40
Volume:850
Avg Vol (3m):3,470,370
Market Cap:1.54B
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOP 0.00%1.54B
IMGN1.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,066.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.70
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback